Chronic Pain

Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.

Researchers analyzed studies from the past two decades on the impact of cannabinoids on neuropathic pain and potential benefits.

A Tilray-funded case series found that cannabinoid treatment provided pain relief and improved other symptoms.

Here, Scott Mazza, Founder of Vitality CBD, compares the effects of the cannabis compounds CBD and THC for use with various conditions.

In the second installment in this webinar series, Dr. Marion McNabb and Dr. Peter Grinspoon discuss implementation of cannabis as a harm reduction agent from a clinical perspective.

A recently published observational study examined the risks of medical cannabis for developing various heart conditions.

A recent study explored cannabinoids as an alternative treatment for neuropathic pain from spinal cord injuries.

A study involving cannabigerol (CBG) injections in mice tested the effectiveness in pain reduction.

Whether someone is struggling with acute or chronic pain, cannabis can be a powerful tool as an alternative or adjunct treatment.

While placebo-controlled randomized trials are lacking, a few early studies show promise for cannabis and arthritis, and surveys show that many arthritis patients are already finding relief using cannabis to treat their symptoms.

This article features real-life stories from a cannabis patient as well as an on-the-ground cannabis nurse.

Katherine Golden, RN and CEO, executive director, and founder of Leaf411, provides a summary on the evidence surrounding cannabis as a treatment for chronic pain patients.

Based on his 13 years of clinical experience, Dr. Dustin Sulak explains strategies in effectively treating chronic pain while reducing or eliminating adverse effects.

A United Kingdom study revealed an association between cannabis products, improved quality of life, and reduced opioid use in chronic pain patients.

The Texas House approved a bill that would allow for more access to the state’s medical cannabis program.

To help clinicians and patients navigate cannabinoid-based medications (CBM), Cannabis and Cannabinoid Research published guidelines based on reviews of studies on CBM and chronic pain.

A recently published case study documents one chronic pain patient’s reduction of prescribed pain medication after being referred to a medical cannabis registry. Prescribed cannabis-based medicinal products (CBMPs) have been legal in the UK since 2018.

One of the recurring challenges in the medical cannabis space is the difficulty in conducting research because of the plant’s Schedule I status. Although there are some researchers diving in with special licenses to conduct clinical studies, there are others that are looking at real-world users to supply data. For instance, Dr. Daniel J. Kruger is a Research Investigator with the Population Study Center at the University of Michigan and Principal Investigator on a study being conducted with the Releaf app. Here, Dr. Kruger shares his interest and background in these types of surveys and his plans for the current study with Releaf on chronic pain.

When a patient isn’t able to access the care or medication that they need in their home country, they aren’t left with much of a choice but to travel to a country that will give them the treatment they need. In part II of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), continues discussing her journey to health, the broken healthcare system hurting medical cannabis patients in the US, and what needs to change to make access better for patients.

What happens when traditional medicine fails a patient? When all recourses have been tried and the patient still suffers? In part I of this interview series, Nikki Lawley, founder of Nikki and the Plant, LLC, and retired licensed practical nurse (LPN), takes us through her journey from a medical professional in the healthcare industry to a brain injury survivor. Lawley also describes the medical cannabis industry from a patient perspective, learning about the medicinal properties of the plant, and finding what ways cannabis could be beneficial to her symptoms.

Colombian-based public health company, Khiron Life Sciences Corp., published the results of its first clinical study on the use of medical cannabis prescribed to patients in treating chronic pain.

Here, Tetragram shares an overview of some of the top four areas users reported on related to pain to see what type of products they are finding useful, how they are consuming it, and more.

In this article, Ruth Fisher explores the prominence of cannabis being used to treat chronic pain patients and data from studies detailing how beneficial it can be.

Here, Dr. Michelle Weiner shares her journey to learning and practicing cannabis medicine.

Patient Ellen Lennox Smith shares her chronic pain story and how cannabis allowed her to live her life again.

Dr. Uwe Blesching provides insight into the exploration of cannabis as a supplement for chronic pain treatment, opioid addiction mitigation, and the mind-body balance.

Nurse Linda Casale discusses her mission to get cannabis on the list of treatments to help treat chronic pain.

Nurse Practitioner Me Fuimaono-Poe discusses how becoming an advocate and assisting with legislation are the best tools to help your state, community, and yourself gain access to cannabis and help others.

Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects.

View our interactive March/April 2021 digital edition